New virtual screening strategy identifies existing drug that inhibits COVID-19 virus: In lab experiments, pralatrexate outperforms remdesivir against SARS-CoV-2 – Science Daily

A novel computational drug screening strategy combined with lab experiments suggest that pralatrexate, a chemotherapy medication originally developed to treat lymphoma, could potentially be repurposed to treat Covid-19. Haiping Zhang of the Shenzhen Institutes of Advanced Technology in Shenzhen, China, and colleagues present these findings in the open-access journal PLOS Computational Biology.With the Covid-19 pandemic causing illness and death worldwide, better treatments are urgently needed. One…

Click here to view the original article.